BioRender 图标

Pericyte 1

Pericyte 1 - Editable icon of Pericyte cell with a round nucleus
[{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58591/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58591/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58590/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58590/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858f/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858f/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858e/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858e/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858d/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858d/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858c/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858c/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858b/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858b/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5858a/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5858a/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58589/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58589/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58588/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58588/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58587/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58587/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58586/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58586/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58585/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58585/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58584/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58584/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58583/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58583/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58582/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58582/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58581/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58581/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58580/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58580/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857f/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857f/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857e/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857e/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857d/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857d/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857c/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857c/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857b/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857b/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5857a/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5857a/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58579/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58579/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58578/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58578/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58577/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58577/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58576/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58576/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58575/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58575/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58574/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58574/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58573/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58573/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58572/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58572/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58571/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58571/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58570/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58570/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856f/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856f/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856e/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856e/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856d/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856d/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856c/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856c/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856b/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856b/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b5856a/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b5856a/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58569/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58569/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58568/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58568/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58567/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58567/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58566/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58566/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58565/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58565/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58564/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58564/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58563/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58563/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58562/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58562/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58561/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58561/5faad17f574dc90028e525dd.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/636427bc6b73320021b58560/5faad17f574dc90028e525dd.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/636427bc6b73320021b58560/5faad17f574dc90028e525dd.png"}]
使用此图标 – 免费
注册无需信用卡。

此图标可在 BioRender 中完全编辑

  • 添加文本、形状及其他图标
  • 搜索 50,000 多种科学准确的图标
  • 重新着色并重新排列每一个图标、线条和标签
  • 导出或分享以满足任何使用需求
Scientist Avatars

加入 400 多万名科学家 的行列,制作可直接用于发表的图表

从图标到成品图表,只需几分钟

  • 搜索 来自 50,000 多个科学准确、经同行评审的图标
  • 自定义 添加标签、形状和更多图标——一切皆可完全编辑
  • 导出 或与协作者分享您的图表
    ‍

图标不合适?探索更多内容。

搜索涵盖 30 多个生命科学领域的 50,000 多个图标。

search icon
arrow-right
pericyte,contractile,BBB blood brain barrier,endothelium,endothelia,epithelial,epithelium,BBB,endothelial,blood,vessel,pericyte
查看更多

尝试使用同义词,或注册以在应用中请求图标。

图像类型

Pericyte 1 icon JPEG

Pericyte 1 icon PNG

Pericyte 1 icon SVG

Pericyte 1 icon GIF

BioRender 图标常见问题解答

How are scientists using the Pericyte 1 icon in their work?

BioRender users often use the Pericyte 1 icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.

我可以在 BioRender 图表或科学插图中使用此图标吗?

Yes, the Pericyte 1 is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Pericyte 1 icon customizable in BioRender?

Most icons in BioRender, including the Pericyte 1 icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

Can I export figures that include the Pericyte 1 icon for publication or presentations?

Yes, figures containing the Pericyte 1 icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

How do I cite BioRender if I use this icon?

Unlock publication permissions with a paid plan, and include 'Created with BioRender.com' in your figure legend, or cite BioRender directly per your journal's guidelines.

Is the Pericyte 1 icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Pericyte 1 icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

什么是 BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Pericyte 1 icon along with our library of more than 30,000 life science icons.

在 BioRender 中使用此图标

立即开始制作专业的科学图表
antibody elements3D Phospholipid illustration

正在寻找科学内容?

浏览超过 5 万个经同行评审、易于使用且免费的图标和模板。

立即寻找您的专属素材
x icon